Futura Medical plc (AIM:FUM)
London · Delayed Price · Currency is GBP · Price in GBX 0.2780
0.00 (0.00%)
Sep 4, 2026, 4:46 PM GMT
Futura Medical Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.24 | 3.4 | 6.6 | 7.71 | 4.03 | 10.37 |
Cash & Short-Term Investments | 1.24 | 3.4 | 6.6 | 7.71 | 4.03 | 10.37 |
Cash Growth | -66.28% | -48.43% | -14.49% | 91.60% | -61.19% | 918.31% |
Accounts Receivable | 1.86 | 0.32 | 1.27 | 1.15 | 0.07 | 0.01 |
Other Receivables | 0.36 | 0.32 | 0.22 | 0.38 | 1.02 | 0.91 |
Receivables | 2.21 | 0.64 | 1.49 | 1.52 | 1.09 | 0.92 |
Inventory | 0 | 0 | 0.46 | 0 | - | - |
Prepaid Expenses | - | 0.43 | 0.96 | 0.09 | 0.2 | 0.07 |
Total Current Assets | 3.46 | 4.47 | 9.5 | 9.33 | 5.31 | 11.36 |
Property, Plant & Equipment | 0.69 | 0.75 | 4.09 | 2.48 | 1.16 | 0.44 |
Total Assets | 4.15 | 5.22 | 13.59 | 11.82 | 6.47 | 11.8 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.39 | 0.56 | 1.49 | 1.01 | 0.32 | 0.98 |
Accrued Expenses | - | 1 | 1.97 | 1.49 | 1 | 0.99 |
Current Unearned Revenue | - | 0.1 | 0.1 | 3.85 | - | - |
Other Current Liabilities | 0.51 | 0.51 | 0.29 | - | 0.43 | 0.11 |
Total Current Liabilities | 1.9 | 2.17 | 3.84 | 6.34 | 1.75 | 2.08 |
Long-Term Unearned Revenue | 0.24 | 0.24 | 0.34 | - | - | - |
Other Long-Term Liabilities | - | - | 0.44 | - | - | - |
Total Liabilities | 2.15 | 2.41 | 4.63 | 6.34 | 1.75 | 2.08 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.16 | 1.16 | 0.61 | 0.6 | 0.58 | 0.57 |
Additional Paid-In Capital | 72.85 | 72.85 | 71.24 | 71.07 | 66.55 | 66.38 |
Retained Earnings | -73.37 | -72.57 | -64.03 | -67.35 | -63.72 | -58.55 |
Comprehensive Income & Other | 1.37 | 1.37 | 1.15 | 1.15 | 1.32 | 1.32 |
Shareholders' Equity | 2.01 | 2.81 | 8.96 | 5.48 | 4.72 | 9.72 |
Total Liabilities & Equity | 4.15 | 5.22 | 13.59 | 11.82 | 6.47 | 11.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 1.24 | 3.4 | 6.6 | 7.71 | 4.03 | 10.37 |
Net Cash Growth | -66.28% | -48.43% | -14.49% | 91.60% | -61.19% | 918.31% |
Net Cash Per Share | 0.00 | 0.01 | 0.02 | 0.03 | 0.01 | 0.04 |
Filing Date Shares Outstanding | 590.58 | 581.33 | 303.7 | 301.41 | 288.05 | 287.15 |
Total Common Shares Outstanding | 590.58 | 581.33 | 303.7 | 301.41 | 288.05 | 287.15 |
Working Capital | 1.56 | 2.3 | 5.66 | 2.99 | 3.56 | 9.28 |
Book Value Per Share | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.03 |
Tangible Book Value | 2.01 | 2.81 | 8.96 | 5.48 | 4.72 | 9.72 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.03 |
Machinery | - | 4.53 | 4.53 | 2.8 | 1.35 | 0.61 |